US4053639A
(en)
*
|
1964-01-24 |
1977-10-11 |
The Boots Company Limited |
Therapeutically active phenylalkane derivatives
|
US3526653A
(en)
*
|
1964-06-15 |
1970-09-01 |
Merck & Co Inc |
Phenylacetamides
|
US3457300A
(en)
*
|
1965-06-11 |
1969-07-22 |
Merck & Co Inc |
Acetic acid type compounds
|
SE363818B
(fr)
*
|
1968-08-15 |
1974-02-04 |
Lilly Co Eli |
|
US3919304A
(en)
*
|
1968-10-25 |
1975-11-11 |
Ciba Geigy Corp |
{62 -Hydroxy-{62 -(cycloalkenylphenyl)alkanoic acids, esters and salts
|
GB1245711A
(en)
*
|
1969-01-13 |
1971-09-08 |
Allen & Hanburys Ltd |
Phenethyl alcohols
|
US3876800A
(en)
*
|
1969-05-12 |
1975-04-08 |
Clin Midy |
Pharmaceutical compositions and methods for treating inflammation and pain
|
US4062895A
(en)
*
|
1969-05-28 |
1977-12-13 |
Eli Lilly And Company |
2-(3-Phenoxyphenyl) propanol
|
GB1271732A
(en)
*
|
1969-07-22 |
1972-04-26 |
Science Union & Cie |
New isobutyl cyclohexenyl derivatives and process for preparing them
|
US3981905A
(en)
*
|
1970-03-16 |
1976-09-21 |
Boots Pure Drug Company Limited |
2-(Substituted phenyl) propionic acids
|
JPS5126429B1
(fr)
*
|
1970-06-18 |
1976-08-06 |
|
|
FR2115026B1
(fr)
*
|
1970-11-24 |
1974-03-22 |
Logeais Labor Jacques |
|
US3898271A
(en)
*
|
1971-06-08 |
1975-08-05 |
Squibb & Sons Inc |
Cyclopropylmethylphenylacetic acids and derivatives
|
US4001301A
(en)
*
|
1971-11-04 |
1977-01-04 |
Syntex Corporation |
6-substituted 2-naphthyl acetic acid derivatives
|
US3927084A
(en)
*
|
1973-01-29 |
1975-12-16 |
Nisshin Flour Milling Co |
Process for the production of 2(4-alkylphenyl)propionic acid
|
JPS5726254B2
(fr)
*
|
1973-05-01 |
1982-06-03 |
|
|
DE2451140A1
(de)
*
|
1973-10-29 |
1975-04-30 |
Eisai Co Ltd |
M-phenoxyphenylpropionsaeurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
|
GB1497044A
(en)
*
|
1974-03-07 |
1978-01-05 |
Prodotti Antibiotici Spa |
Salts of phenyl-alkanoic acids
|
JPS582934B2
(ja)
*
|
1974-07-29 |
1983-01-19 |
ニツシンセイフン カブシキガイシヤ |
2−(置換アリ−ル)−プロピオン酸の製法
|
JPS5129466A
(en)
*
|
1974-08-31 |
1976-03-12 |
Sanwa Kagaku Kenkyusho Co |
Arufua *44 chikanfueniru ** arufua arukirusakusan no seiho
|
FR2287217A1
(fr)
*
|
1974-10-08 |
1976-05-07 |
Hommel Ag |
Nouveaux acides phenylalcanoiques substitues et leurs derives, ainsi que procede de leur preparation et medicaments
|
JPS5838415B2
(ja)
*
|
1974-12-06 |
1983-08-23 |
サカキダ タイジ |
アルフア − フエニルプロピオンサンノ セイゾウホウ
|
JPS51108031A
(en)
*
|
1975-03-13 |
1976-09-25 |
Jasuto Sa Kuimiko Fuarumaseute |
22 * 44 isobuchirufueniru * rakusannoseizoho
|
JPS51108032A
(en)
*
|
1975-03-13 |
1976-09-25 |
Jasuto Sa Kuimiko Fuarumaseute |
22 * 44 isobuchirufueniru * rakusannoseizoho
|
JPS51108033A
(en)
*
|
1975-03-13 |
1976-09-25 |
Jasuto Sa Kuimiko Fuarumaseute |
22 * 44 isobuchirufueniru * rakusannoseizoho
|
US4188491A
(en)
*
|
1975-04-04 |
1980-02-12 |
The Boots Company Limited |
Preparation of therapeutic compounds
|
US4151302A
(en)
*
|
1975-06-28 |
1979-04-24 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Araliphatic dihalogen compounds composition and method of use
|
US4145557A
(en)
|
1975-08-28 |
1979-03-20 |
Eli Lilly And Company |
(Phenoxyphenyl) alkyl acetates, propionates, and carbamates
|
DE2646792C2
(de)
*
|
1975-10-23 |
1985-05-09 |
Mitsubishi Petrochemical Co., Ltd., Tokio/Tokyo |
Verfahren zur Herstellung einer α-(arylsubstituierten)-Propionsäure und/oder eines Esters derselben
|
JPS5271434A
(en)
*
|
1975-12-08 |
1977-06-14 |
Sadao Mori |
Production of *alphaa44 isobutylphenyl*propionic acid
|
US4150137A
(en)
*
|
1975-12-24 |
1979-04-17 |
Hisamitsu Pharmaceutical Co. Inc. |
Pyridylalkyl esters of 2-(p-isobutylphenyl)acetic acid and propionic acids and use
|
JPS5826744B2
(ja)
*
|
1975-12-24 |
1983-06-04 |
ヒサミツセイヤク カブシキガイシヤ |
シンキナプロピオンサン エステルユウドウタイノセイゾウホウ
|
US4085139A
(en)
*
|
1975-12-29 |
1978-04-18 |
The Upjohn Company |
2-Decarboxy-2-amino-methyl-PGE and PGD analogs
|
NL7709681A
(nl)
*
|
1976-09-08 |
1978-03-10 |
Sandoz Ag |
Werkwijzen voor het bereiden en toepassen van fenylazijnzuurderivaten.
|
US4335251A
(en)
*
|
1976-12-08 |
1982-06-15 |
Hisamitsu Pharmaceutical Co. Inc. |
Phenyl-i-propionic acid esters and pharmaceutical use thereof
|
US4161538A
(en)
*
|
1977-04-05 |
1979-07-17 |
Sankyo Company Limited |
Substituted phenylacetic acid derivatives and process for the preparation thereof
|
US4145440A
(en)
*
|
1977-08-18 |
1979-03-20 |
The Upjohn Company |
Liquid suspension of an aluminum salt of ibuprofen
|
DD141422A5
(de)
*
|
1978-01-27 |
1980-04-30 |
Schering Ag |
Verfahren zur herstellung von phenylessigsaeure-derivaten
|
CA1137506A
(fr)
*
|
1978-03-17 |
1982-12-14 |
Ulf Fischer |
Derives d'acide carbamique
|
JPS54163545A
(en)
*
|
1978-06-10 |
1979-12-26 |
Taisho Pharmaceutical Co Ltd |
Organic carboxylic acid derivative
|
US4186270A
(en)
*
|
1978-12-26 |
1980-01-29 |
The Dow Chemical Company |
Process for making 2-(4-isobutylphenyl)propionic acid and related compounds
|
IT1109200B
(it)
*
|
1979-02-20 |
1985-12-16 |
Montedison Spa |
Processo per la preparazione di esteri di acidi arilacetici da alfa-alo-alchilarilchetoni
|
DE3022599A1
(de)
*
|
1979-06-18 |
1981-01-08 |
Glaxo Group Ltd |
Alkansaeurederivate
|
DE3018114A1
(de)
*
|
1980-05-12 |
1981-11-19 |
Henkel Kgaa |
Hautpflegemittel
|
US4361580A
(en)
*
|
1980-06-20 |
1982-11-30 |
The Upjohn Manufacturing Company |
Aluminum ibuprofen pharmaceutical suspensions
|
DE3026402A1
(de)
*
|
1980-07-11 |
1982-02-04 |
Syntex Corp., Palo Alto, Calif. |
Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
|
US4341798A
(en)
*
|
1980-07-22 |
1982-07-27 |
Laboratori Prophin S.P.A. |
Amide derivatives of p-isobutyl-phenyl-propionic acids and related pharmaceutical compositions
|
AT370721B
(de)
*
|
1981-02-24 |
1983-04-25 |
Ciba Geigy Ag |
Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
|
AT380166B
(de)
*
|
1981-02-16 |
1986-04-25 |
Ciba Geigy Ag |
Verfahren zur herstellung topisch applizierbarer pharmazeutischer praeparate, enthaltend salze von alkancarbonsaeuren
|
US4431836A
(en)
*
|
1981-02-23 |
1984-02-14 |
Uop Inc. |
Hydrogenation using chitin and chitosan based immobilized metal catalysts
|
IT1144911B
(it)
*
|
1981-03-19 |
1986-10-29 |
Pharmatec Spa |
Composizione farmaceutica a rilascio controllato contenente ibuprofen
|
JPS57203035A
(en)
*
|
1981-06-05 |
1982-12-13 |
Taisho Pharmaceut Co Ltd |
Carboxylic acid ester
|
US4447451A
(en)
*
|
1981-07-20 |
1984-05-08 |
The Upjohn Manufacturing Company M |
Treatment of adult respiratory distress syndrome
|
DE3237475C2
(de)
*
|
1981-10-14 |
1984-05-30 |
Kureha Kagaku Kogyo K.K., Nihonbashi, Tokyo |
2-[p-(2-substituierte oder unsubstituierte-3,3,3-Trifluorpropyl)-phenyl]-propionsäuren, deren Salze sowie solche Verbindungen enthaltende Arzneimittel
|
US4404210A
(en)
*
|
1982-06-30 |
1983-09-13 |
E. I. Du Pont De Nemours And Company |
Analgesic mixture of nalbuphine and ibuprofen
|
IE55189B1
(en)
*
|
1982-07-08 |
1990-06-20 |
Wyeth John & Brother Ltd |
Pharmaceutical compositions
|
US4476248A
(en)
*
|
1983-02-28 |
1984-10-09 |
The Upjohn Company |
Crystallization of ibuprofen
|
JPS59212439A
(ja)
*
|
1983-05-19 |
1984-12-01 |
Taisho Pharmaceut Co Ltd |
スチレン誘導体
|
US4490391A
(en)
*
|
1983-08-08 |
1984-12-25 |
Flint John E |
Composition for shock treatment
|
JPS6038323A
(ja)
*
|
1983-08-10 |
1985-02-27 |
Sankyo Co Ltd |
眼科用消炎剤
|
DE3332505A1
(de)
*
|
1983-09-09 |
1985-03-28 |
Henkel Kgaa |
Sebosuppressive kosmetische mittel, enthaltend alkoxyarylalkanole
|
US5166141A
(en)
*
|
1983-11-01 |
1992-11-24 |
Scripps Clinic And Research Foundation |
Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
|
FR2577921B1
(fr)
*
|
1985-02-22 |
1988-05-06 |
Sintenovo Sa |
Procede de preparation d'acides 2-(4-alkylphenyl)-propioniques
|
US4684666A
(en)
*
|
1986-08-19 |
1987-08-04 |
Haas Pharmaceuticals, Inc. |
Stabilized liquid analgesic compositions
|
JPS62142138A
(ja)
*
|
1986-11-28 |
1987-06-25 |
Sanwa Kagaku Kenkyusho:Kk |
2−(6−メトキシ−2−ナフチル)プロピオン酸の製法
|
US4752616A
(en)
*
|
1987-06-29 |
1988-06-21 |
E. R. Squibb & Sons, Inc. |
Arylthioalkylphenyl carboxylic acids, compositions containing same and method of use
|
US5240712A
(en)
*
|
1987-07-17 |
1993-08-31 |
The Boots Company Plc |
Therapeutic agents
|
US4861797A
(en)
*
|
1987-10-15 |
1989-08-29 |
Oratech Pharmaceutical Development Corporation |
Liquid ibuprofen compositions and methods of making them
|
US4859704A
(en)
*
|
1987-10-15 |
1989-08-22 |
Oratech Pharmaceutical Development Corporation |
Water soluble ibuprofen compositions and methods of making them
|
US5179124A
(en)
*
|
1988-01-25 |
1993-01-12 |
University Of Iowa Research Foundation |
Anti-inflammatory for use in external and internal eye inflammations
|
US4968718A
(en)
*
|
1988-01-25 |
1990-11-06 |
University Of Iowa Research Foundation |
Topically effective, nonsteroidal drug for use in external and internal eye inflammations
|
DE3802619C1
(fr)
*
|
1988-01-29 |
1989-09-07 |
Hoechst Ag, 6230 Frankfurt, De |
|
US5011852A
(en)
*
|
1988-07-25 |
1991-04-30 |
Applied Analytical Industries, Inc. |
Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
|
US5059626A
(en)
*
|
1988-07-25 |
1991-10-22 |
Applied Analytical Industries, Inc. |
Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
|
US5001283A
(en)
*
|
1988-10-06 |
1991-03-19 |
Mobil Oil Corp. |
Process for preparing aromatic alkanols
|
DE3838431A1
(de)
*
|
1988-11-12 |
1990-05-17 |
Bayer Ag |
Ibuprofen-brausezubereitungen
|
US5260477A
(en)
*
|
1988-12-21 |
1993-11-09 |
Nippon Petrochemicals Co., Ltd. |
Method for preparing alpha-(4-isobutylphenyl)propionic acid or its precursor
|
US4910337A
(en)
*
|
1989-01-27 |
1990-03-20 |
Mine Safety Appliances Company |
Process for the preparation of α-arylalkanoic acids
|
DE4015781A1
(de)
*
|
1989-05-16 |
1990-12-13 |
Puetter Medice Chem Pharm |
Verfahren zur herstellung optisch aktiver 2-aryl-alkansaeuren, insbesondere von 2-aryl-propionsaeuren
|
NZ234143A
(en)
*
|
1989-06-28 |
1991-10-25 |
Mcneil Ppc Inc |
Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
|
US4990681A
(en)
*
|
1989-12-04 |
1991-02-05 |
Curtis Thomas A |
Method for removing hydrogen fluoride from mixtures comprising aromatic ketones
|
US5185469A
(en)
*
|
1989-12-04 |
1993-02-09 |
Hoechst Celanese Corp. |
Process for acylation or alkylation of aromatic compounds in hydrogen fluoride
|
US4994596A
(en)
*
|
1990-01-29 |
1991-02-19 |
Ethyl Corporation |
Cyanoalkenylation process
|
CA2076983A1
(fr)
*
|
1990-04-11 |
1991-10-12 |
Robert Wu-Wei Shen |
Revetement en lit fluidise permettant de masquer le gout de l'ibuprofene
|
US5248682A
(en)
*
|
1991-01-31 |
1993-09-28 |
Warner-Lambert Company |
2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
|
US5177079A
(en)
*
|
1991-01-31 |
1993-01-05 |
Warner-Lambert Company |
2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
|
EP0584108B1
(fr)
|
1991-05-13 |
2000-08-16 |
The Boots Company PLC |
Composition pharmaceutique comprenant un sel d'ibuprofene
|
DE4120917A1
(de)
*
|
1991-06-25 |
1993-01-07 |
Basf Ag |
Ester von fettsaeuren mit aminoalkoholen zur verwendung bei der bekaempfung von krankheiten
|
DE4120916A1
(de)
*
|
1991-06-25 |
1993-01-07 |
Basf Ag |
Omega-3 mehrfach ungesaettigte fettsaeurederivate, ihre herstellung und verwendung
|
US5360938A
(en)
*
|
1991-08-21 |
1994-11-01 |
Union Carbide Chemicals & Plastics Technology Corporation |
Asymmetric syntheses
|
US5198594A
(en)
*
|
1991-11-27 |
1993-03-30 |
Amoco Corporation |
Alkylation of alkylaromatics promoted by sonicated alkali metal
|
WO1995009831A1
(fr)
*
|
1993-10-06 |
1995-04-13 |
Nicox S.A. |
Esters nitriques dotes d'une activite anti-inflammatoire et/ou analgesique et leur procede de preparation
|
DE4402403A1
(de)
*
|
1994-01-27 |
1995-08-03 |
Bayer Ag |
Verfahren zur Herstellung von substituierten Phenylessigsäurederivaten und neue Zwischenprodukte
|
US5434302A
(en)
*
|
1994-02-18 |
1995-07-18 |
Paradies; H. Henrich |
Method for the preparation of optically active 2-aryl alkyl aldehydes and formation of 2-aryl-alkanoic acids therefrom
|
US5621140A
(en)
*
|
1994-12-22 |
1997-04-15 |
Syntex (U.S.A.) Inc. |
Resolution of ibuprofen
|
US5538959A
(en)
*
|
1995-01-26 |
1996-07-23 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
CA2178686A1
(fr)
*
|
1995-06-13 |
1996-12-14 |
Leslie G. Humber |
Formulations orales de s(+)-etodolac
|
TW442287B
(en)
*
|
1995-06-13 |
2001-06-23 |
American Home Produits Corp |
Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
|
US6348216B1
(en)
*
|
1996-06-10 |
2002-02-19 |
Knoll Pharmaceutical Company |
Ibuprofen and narcotic analgesic compositions
|
US6361794B1
(en)
|
1996-06-12 |
2002-03-26 |
Basf Corporation |
Method of making ibuprofen and narcotic analgesic composition
|
AU3641597A
(en)
|
1996-06-21 |
1998-01-07 |
Advanced Research And Technology Institute, Inc. |
Methods and compositions comprising r-ibuprofen
|
US5914129A
(en)
*
|
1996-07-23 |
1999-06-22 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
US6080888A
(en)
*
|
1997-01-08 |
2000-06-27 |
Albemarle Corporation |
Preparation of olefinic compounds and carboxylic derivatives thereof
|
US5792886A
(en)
*
|
1997-01-08 |
1998-08-11 |
Albemarle Corporation |
Production of racemic 2-(6-methoxy-2-naphthyl) propionic acid of precursors thereof
|
US6096920A
(en)
*
|
1997-01-08 |
2000-08-01 |
Albemarle Corporation |
Preparation of carboxylic compounds and their derivatives
|
KR19990026514A
(ko)
*
|
1997-09-25 |
1999-04-15 |
구광시 |
페닐 프로피온산 유도체의 신규 제조방법
|
US5859292A
(en)
*
|
1997-12-11 |
1999-01-12 |
Albemarle Corporation |
Preparation of high purity sodium (S)-2(6-methoxy-2-naphthyl)propionate
|
US5874614A
(en)
*
|
1997-12-11 |
1999-02-23 |
Albemarle Corporation |
Sodium (S)-2-(6-methoxy-2-naphthyl)propionate monohydrate
|
IT1303685B1
(it)
*
|
1998-10-30 |
2001-02-23 |
Dompe Spa |
Procedimento per la preparazione di acidi alfa-arilalcanoici
|
US6268526B1
(en)
|
1998-12-16 |
2001-07-31 |
Albemarle Corporation |
Palladium catalyzed carbonylation process utilizing aromatic substituted alcohols and/or aromatic substituted alkyl halides
|
IT1308633B1
(it)
|
1999-03-02 |
2002-01-09 |
Nicox Sa |
Nitrossiderivati.
|
IT1318674B1
(it)
*
|
2000-08-08 |
2003-08-27 |
Nicox Sa |
Faramaci per l'incontinenza.
|
IT1318673B1
(it)
*
|
2000-08-08 |
2003-08-27 |
Nicox Sa |
Farmaci per le disfunzioni sessuali.
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
US6436916B1
(en)
|
2000-10-12 |
2002-08-20 |
Alvin Guttag |
Ibuprofen-aspirin and hydroxymethylacylfulvene analogs
|
US7090859B2
(en)
*
|
2002-12-13 |
2006-08-15 |
Ronald Thomas Haas |
Ketoprofen compositions and methods of making them
|
US20050137262A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Hu Patrick C. |
Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
|
US7582679B2
(en)
*
|
2006-02-03 |
2009-09-01 |
Pharmaceutics International Incorporated |
Compositions containing solid ibuprofen concentrates and methods of making solid ibuprofen concentrates
|
JP2009529057A
(ja)
|
2006-03-08 |
2009-08-13 |
コートリア・コーポレーシヨン |
Cox−関連胃損傷を予防するための非−選択的cox阻害剤との組み合わせ療法
|
CL2007002425A1
(es)
*
|
2006-08-22 |
2008-06-27 |
Albermarle Corp |
Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
|
US20080317684A1
(en)
*
|
2006-09-06 |
2008-12-25 |
Isw Group, Inc. |
Topical Compositions
|
US20100292280A1
(en)
*
|
2007-04-15 |
2010-11-18 |
Oron Zachar |
Anti-pyretic vasodilators
|
EP2011502A1
(fr)
*
|
2007-07-04 |
2009-01-07 |
Freie Universität Berlin |
Composés contenant du silicone et utilisés en tant qu'anti-inflammatoires
|
US20090110755A1
(en)
*
|
2007-10-30 |
2009-04-30 |
Alexander Mauskop |
Compositions and Methods for Preventing Migraines
|
BRPI1015124B8
(pt)
*
|
2009-05-04 |
2021-05-25 |
Prometic Biosciences Inc |
compostos aromáticos substituídos para a prevenção ou tratamento de distúrbios sanguíneos; distúrbios renais, nefropatias e/ou complicações do distúrbio renal; doenças relacionadas com inflamação; e distúrbios relacionados ao estresse oxidativo, usos farmacêuticos dos mesmos e composição farmacêutica comprendendo ditos compostos
|
WO2010127448A1
(fr)
*
|
2009-05-04 |
2010-11-11 |
Prometic Biosciences Inc. |
Sels d'acide 3-penthylphénylacétique et utilisations pharmaceutiques de ceux-ci
|
ES2353541B1
(es)
|
2009-07-30 |
2011-09-20 |
Farmalider, S.A. |
Combinacion de ingredientes activos cosmeticos y composicion cosmetica obtenida a partir de la misma, y su utilizacion.
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US9271950B2
(en)
|
2010-10-29 |
2016-03-01 |
Infirst Healthcare Limited |
Compositions for treating chronic inflammation and inflammatory diseases
|
US8895536B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating chronic inflammation and inflammatory diseases
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US9737500B2
(en)
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US9504664B2
(en)
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US10695431B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US10695432B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US10525054B2
(en)
|
2011-11-07 |
2020-01-07 |
Inheris Biopharma, Inc. |
Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound
|
JP6593993B2
(ja)
|
2011-11-07 |
2019-10-23 |
ネクター セラピューティクス |
オピオイドアゴニスト化合物と鎮痛性化合物との組成物、剤形、および同時投与
|
WO2013154512A1
(fr)
|
2012-04-13 |
2013-10-17 |
Mahmut Bilgic |
Formulations pharmaceutiques contenant du dexibuprofène
|
WO2013154511A1
(fr)
|
2012-04-13 |
2013-10-17 |
Mahmut Bilgic |
Formulations de comprimés pelliculés comprenant du dexibuprofène
|
US9320729B2
(en)
|
2012-05-18 |
2016-04-26 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
|
EP2730271B1
(fr)
|
2012-11-11 |
2018-01-24 |
Symrise AG |
Compositions aqueuses
|
ES2701758T3
(es)
|
2013-02-27 |
2019-02-25 |
Symrise Ag |
Extracto de jengibre para la protección de citoblastos
|
US9050302B2
(en)
|
2013-03-01 |
2015-06-09 |
Jazz Pharmaceuticals Ireland Limited |
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
|
ES2540151B1
(es)
|
2013-10-11 |
2016-02-29 |
Farmalider S.A. |
Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
|
EP2862852B1
(fr)
|
2013-10-18 |
2018-07-04 |
Symrise AG |
Derivees d'urée por la protection de cellules souches
|
WO2015117987A1
(fr)
|
2014-02-05 |
2015-08-13 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Formulations effervescentes comprenant de l'ibuprofène et de la n-acétylcystéine
|
EP2921157B1
(fr)
|
2014-03-18 |
2017-08-16 |
Symrise AG |
Dioxyde de titane pelliculé pour la reduction d'effet de décoloration sur la peau
|
EP2939710B1
(fr)
|
2014-04-29 |
2020-06-17 |
Symrise AG |
Mélanges actifs
|
US9993452B2
(en)
|
2014-12-05 |
2018-06-12 |
Vireo Systems, Inc. |
Compositions and methods for treatment of inflammation
|
EP3045161A1
(fr)
|
2015-01-18 |
2016-07-20 |
Symrise AG |
Compositions actives comprenant du 1,2-hexanediol et du 1,2-octanediol
|
EP3790970A1
(fr)
|
2018-05-07 |
2021-03-17 |
Alnylam Pharmaceuticals Inc. |
Administration extra-hépatique
|
JP7470107B2
(ja)
|
2018-09-28 |
2024-04-17 |
アルナイラム ファーマシューティカルズ, インコーポレイテッド |
トランスサイレチン(TTR)iRNA組成物及びTTR関連眼疾患を治療又は予防するためのその使用方法
|
US20220211743A1
(en)
|
2019-05-17 |
2022-07-07 |
Alnylam Pharmaceuticals, Inc. |
Oral delivery of oligonucleotides
|
MX2022000373A
(es)
|
2019-07-09 |
2022-02-10 |
Farmalider Sa |
Combinacion de ibuprofeno y tramadol para aliviar el dolor.
|
AU2020378414A1
(en)
|
2019-11-06 |
2022-05-26 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|
WO2021092145A1
(fr)
|
2019-11-06 |
2021-05-14 |
Alnylam Pharmaceuticals, Inc. |
Composition d'arni de la transthyrétine (ttr) et ses procédés d'utilisation pour le traitement ou la prévention de maladies oculaires associées à ttr
|
EP4061945A1
(fr)
|
2019-11-22 |
2022-09-28 |
Alnylam Pharmaceuticals, Inc. |
Compositions d'agent arni d'ataxine 3 (atxn3) et leurs procédés d'utilisation
|
CN114828829A
(zh)
|
2019-12-23 |
2022-07-29 |
纽特拉艾森索非处方药公司 |
包含布洛芬和去氧肾上腺素的液体组合物
|
AU2021220765A1
(en)
|
2020-02-10 |
2022-09-01 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for silencing VEGF-A expression
|
WO2021178607A1
(fr)
|
2020-03-05 |
2021-09-10 |
Alnylam Pharmaceuticals, Inc. |
Compositions d'arni de composant c3 du complément et leurs procédés d'utilisation pour le traitement ou la prévention de maladies associées au composant c3 du complément
|
AR121769A1
(es)
|
2020-04-06 |
2022-07-06 |
Alnylam Pharmaceuticals Inc |
Composiciones y métodos para el silenciamiento de la expresión de myoc
|
AU2021251754A1
(en)
|
2020-04-07 |
2022-11-03 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for silencing SCN9A expression
|
US20230257745A1
(en)
|
2020-07-10 |
2023-08-17 |
Alnylam Pharmaceuticals, Inc. |
Circular siRNAs
|
KR20220058313A
(ko)
|
2020-10-30 |
2022-05-09 |
신신제약 주식회사 |
이부프로펜을 함유하는 경피 흡수 제제
|
EP4367237A2
(fr)
|
2021-07-09 |
2024-05-15 |
Alnylam Pharmaceuticals, Inc. |
Composés bis-arni pour administration au snc
|
WO2023220744A2
(fr)
|
2022-05-13 |
2023-11-16 |
Alnylam Pharmaceuticals, Inc. |
Oligonucléotides à boucle simple brin
|
WO2024073732A1
(fr)
|
2022-09-30 |
2024-04-04 |
Alnylam Pharmaceuticals, Inc. |
Agents arn double brin modifiés
|
WO2024216155A1
(fr)
|
2023-04-12 |
2024-10-17 |
Alnylam Pharmaceuticals, Inc. |
Administration extrahépatique d'agents d'arn double brin
|
WO2024238385A2
(fr)
|
2023-05-12 |
2024-11-21 |
Alnylam Pharmaceuticals, Inc. |
Oligonucléotides à boucle simple brin
|